If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update - March 2022

27 Apr 2022 07:00

RNS Number : 4241J
Honeycomb Investment Trust PLC
27 April 2022
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

27 April 2022

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 31 March 2022 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 31 March 2022 on a cum-income basis was 1,019.0 pence, based on a NAV of £358.9 million, and on an ex-income basis was 1,018.0 pence, based on a NAV of £358.5 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

Honeycomb delivered a NAV return of 0.66% for the month, which is equivalent to 7.8% per annum. NAV return was driven by strong risk adjusted yield of 9.0%. This is in-line with the Q1 total risk adjusted yield, driving a 7.9% NAV return for the quarter.

Net Investment Assets increased in the month to £586m, from £580m at the end of Feb. This was driven by drawdowns on a senior electric vehicle fleet financing facility as well as net deployment of £7.3m across the senior real estate debt facilities.

The pipeline of new opportunities is strong with c£400m of well progressed deals across Europe and is diversified across a range of sub sectors including micro mobility, small balance SME loans and insurance run off financing. Whilst the outlook for our target market remains positive, the manager Pollen Street Capital remains very focused on the broader macro-economic environment. PSC also continues to see opportunities in sustainability-oriented sectors offering attractive risk adjusted returns whilst also making a positive impact from an ESG perspective.

Despite the more challenging macro-outlook, PSC believes that asset backed direct lending represents a resilient asset class that delivers strong relative value versus other private credit opportunities and publicly traded comparables. The combination of asset backing via large diverse pools of financial and hard assets along with bespoke structuring delivers strong downside protection with a significant margin of safety as well as premium returns.

Proprietary data systems and comprehensive data collection provide the manager with regular and detailed data, and strong transparent relationships with our lending partners enable the manager to closely monitor underlying performance. Detailed monitoring of the portfolio provides reassurance that, despite broader economic concerns, the investment portfolio remains in a strong position.

In response to the unfortunate events in Ukraine, the Honeycomb Board reported, on 11 March 2022, that the Company does not have any direct exposure to Russia. Further, the Company announced, via an RNS on 21 March, that it now intends to commence a share buyback programme, commencing on that date and expected to end no later than 29 April 2022. The policy is to consider conducting share buybacks when trading at a discount of more than 5%. Details of the ongoing programme are updated through RNS postings on the London Stock Exchange.

Finally, the Board was pleased to note that Capital Finance International magazine has named Pollen Street Capital Best Responsible Alternative Investment Team UK for the second consecutive year. The judging panel also noted Pollen Street Capital's prioritisation of lasting impact backing companies and credit partners that help consumers to make greener choices, increase their access to finance and SMEs to promote job creation and socioeconomic growth.

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

hitcosec@linkgroup.co.uk 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBUGDSSXDDGDL
Date   Source Headline
21st Sep 20187:01 amRNSAugust Factsheet
21st Sep 20187:00 amRNSNet Asset Value
5th Sep 20187:00 amRNSDividend Declaration
5th Sep 20187:00 amRNSHalf-year Report 2018
21st Aug 20187:00 amRNSMonthly Update - 31st July 2018
21st Aug 20187:00 amRNSNet Asset Value - 31st July 2018
20th Jul 20187:00 amRNSMonthly Update - Factsheet June 30th 2018
20th Jul 20187:00 amRNSNet Asset Value - June 30th 2018
21st Jun 20183:17 pmRNSNet Asset Value - 31st May 2018 - Replacement
21st Jun 20187:00 amRNSMonthly Update - May 2018
21st Jun 20187:00 amRNSNet Asset Value(s)
8th Jun 20185:42 pmRNSResult of AGM
25th May 20185:29 pmRNSNet Asset Value - 30 April 2018 - Replacement
21st May 20187:00 amRNSNet Asset Value - 30 April 2018
21st May 20187:00 amRNSMonthly Update - 30 April 2018
9th May 20184:28 pmRNSAGM and Financial Statements Notification-Dec 2017
2nd May 20187:00 amRNSHolding(s) in Company
30th Apr 20187:00 amRNSAnnual Report and Audited Financial Statements
25th Apr 20187:00 amRNSHolding(s) in Company - TR1 Announcement
19th Apr 20184:30 pmRNSResult of Placing
19th Apr 20187:00 amRNSProposed Placing
16th Apr 20187:25 amRNSChange of Registered Office
12th Apr 20187:00 amRNSMonthly Update - March 2018
12th Apr 20187:00 amRNSDividend Declaration
12th Apr 20187:00 amRNSNet Asset Value - March 2018
5th Apr 201810:00 amRNSHolding(s) in Company - TR1 Notification
21st Mar 20187:00 amRNSMonthly update - February 28th 2018
21st Mar 20187:00 amRNSNet Asset Value - February 2018
8th Mar 20184:00 pmRNSSupplementary Prospectus
21st Feb 20187:00 amRNSMonthly Update - 31st January 2018
21st Feb 20187:00 amRNSNet Asset Value(s)
21st Feb 20187:00 amRNSDividend Declaration
23rd Jan 20187:00 amRNSHolding(s) in Company - TR1 Notification
22nd Jan 20187:00 amRNSMonthly Update - December 2017
22nd Jan 20187:00 amRNSNet Asset Value(s)
21st Dec 20177:00 amRNSMonthly Update - November
21st Dec 20177:00 amRNSNet Asset Value(s)
28th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Nov 20172:20 pmRNSDividend Declaration - Replacement
21st Nov 20177:00 amRNSMonthly Update - October 2017
21st Nov 20177:00 amRNSNet Asset Value(s) - October 2017
21st Nov 20177:00 amRNSDividend Declaration
16th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
20th Oct 20177:00 amRNSMonthly Update - September 2017
20th Oct 20177:00 amRNSNet Asset Value - September 2017
21st Sep 20177:00 amRNSMonthly update - August 2017
21st Sep 20177:00 amRNSNet Asset Value - August 2017
31st Aug 20177:00 amRNSDividend Declaration - Q2 2017
31st Aug 20177:00 amRNSFinancial Statement Announcement
31st Aug 20177:00 amRNSHalf-year Report 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.